Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elena Castro

Showing results (171-180 of 194) with videos related to

Pageof 20
Sort By:
European Urology Oncology|October 14, 2023
Prospective Assessment of Bone Metabolism Biomarkers and Survival in Metastatic Castration-resistant Prostate Cancer Patients Treated with Radium-223: The PRORADIUM StudyNuria Romero-Laorden, David Lorente, Guillermo de Velasco, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2019
PROREPAIR-B: A Prospective Cohort Study of the Impact of Germline DNA Repair Mutations on the Outcomes of Patients With Metastatic Castration-Resistant Prostate CancerElena Castro, Nuria Romero-Laorden, Angela Del Pozo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2013
Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancerElena Castro, Chee Goh, David Olmos, et al.
European Journal of Cancer (Oxford, England : 1990)|March 27, 2023
Impact of concurrent tumour events on the prostate cancer outcomes of germline BRCA2 mutation carriersRebeca Lozano, Elena Castro, Fernando Lopez-Campos, et al.
JAMA Network Open|October 28, 2020
Activity of Platinum-Based Chemotherapy in Patients With Advanced Prostate Cancer With and Without DNA Repair Gene AberrationsSabine Schmid, Aurelius Omlin, Celestia Higano, et al.
Cancer Discovery|July 2, 2026
Germline CDK12 variants in aggressive prostate cancerSofie H Tolmeijer, Corinne Maurice-Dror, Shahneen Sandhu, et al.
European Urology|July 28, 2018
Patient-derived Models of Abiraterone- and Enzalutamide-resistant Prostate Cancer Reveal Sensitivity to Ribosome-directed TherapyMitchell G Lawrence, Daisuke Obinata, Shahneen Sandhu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 11, 2025
oDigital pathology biomarkers for guiding radiotherapy-based treatment concepts in prostate cancer - a systematic review and expert consensusConstantinos Zamboglou, William De Doncker, Andreas Thomas Christoforou, et al.
European Urology|July 3, 2026
Diagnosis and Staging of Patients with Prostate Cancer: Report from the 2025 Advanced Prostate Cancer Consensus Conference (APCCC) DiagnosticsStefano Fanti, Fabio Turco, Bertrand Tombal, et al.
Nature|June 29, 2017
mTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancerAmaia Zabala-Letona, Amaia Arruabarrena-Aristorena, Natalia Martín-Martín, et al.
Pageof 20

Showing results (171-180 of 194) with videos related to

Sort By:
Pageof 20
European Urology Oncology|October 14, 2023
Prospective Assessment of Bone Metabolism Biomarkers and Survival in Metastatic Castration-resistant Prostate Cancer Patients Treated with Radium-223: The PRORADIUM StudyNuria Romero-Laorden, David Lorente, Guillermo de Velasco, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2019
PROREPAIR-B: A Prospective Cohort Study of the Impact of Germline DNA Repair Mutations on the Outcomes of Patients With Metastatic Castration-Resistant Prostate CancerElena Castro, Nuria Romero-Laorden, Angela Del Pozo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2013
Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancerElena Castro, Chee Goh, David Olmos, et al.
European Journal of Cancer (Oxford, England : 1990)|March 27, 2023
Impact of concurrent tumour events on the prostate cancer outcomes of germline BRCA2 mutation carriersRebeca Lozano, Elena Castro, Fernando Lopez-Campos, et al.
JAMA Network Open|October 28, 2020
Activity of Platinum-Based Chemotherapy in Patients With Advanced Prostate Cancer With and Without DNA Repair Gene AberrationsSabine Schmid, Aurelius Omlin, Celestia Higano, et al.
Cancer Discovery|July 2, 2026
Germline CDK12 variants in aggressive prostate cancerSofie H Tolmeijer, Corinne Maurice-Dror, Shahneen Sandhu, et al.
European Urology|July 28, 2018
Patient-derived Models of Abiraterone- and Enzalutamide-resistant Prostate Cancer Reveal Sensitivity to Ribosome-directed TherapyMitchell G Lawrence, Daisuke Obinata, Shahneen Sandhu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 11, 2025
oDigital pathology biomarkers for guiding radiotherapy-based treatment concepts in prostate cancer - a systematic review and expert consensusConstantinos Zamboglou, William De Doncker, Andreas Thomas Christoforou, et al.
European Urology|July 3, 2026
Diagnosis and Staging of Patients with Prostate Cancer: Report from the 2025 Advanced Prostate Cancer Consensus Conference (APCCC) DiagnosticsStefano Fanti, Fabio Turco, Bertrand Tombal, et al.
Nature|June 29, 2017
mTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancerAmaia Zabala-Letona, Amaia Arruabarrena-Aristorena, Natalia Martín-Martín, et al.
Pageof 20